Osilodrostat

(Isturisa®)

Isturisa®

Drug updated on 11/15/2023

Dosage FormTablet (oral: 1 mg, 5 mg, 10 mg)
Drug ClassCortisol synthesis inhibitors
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of adult patients with Cushing’s disease for whom pituitary surgery is not an option or has not been curative.

Product Monograph / Prescribing Information

Document TitleYearSource
Isturisa (osilodrostat) Prescribing Information.2020Recordati Rare Disease, Inc. Lebanon, NJ

Systematic Reviews / Meta-Analyses